Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 6, 2021; 9(34): 10595-10603
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10595
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10595
Indicators | T1 | T2 | T3 |
OI (mmHg) | |||
Remimazolam group (n = 40) | 398.6 ± 24.7 | 357.6 ± 28.0 | 381.8 ± 30.0 |
Propofol group (n = 40) | 390.1 ± 26.3 | 338.1 ± 30.5 | 359.4 ± 33.8 |
t value | 1.490 | 2.979 | 3.135 |
P value | 0.140 | 0.004 | 0.002 |
RI | |||
Remimazolam group (n = 40) | 0.59 ± 0.17 | 0.90 ± 0.23 | 0.50 ± 0.18 |
Propofol group (n = 40) | 0.62 ± 0.17 | 0.94 ± 0.21 | 0.56 ± 0.20 |
t value | -0.789 | -0.812 | -1.410 |
P value | 0.432 | 0.419 | 0.162 |
- Citation: Tang F, Yi JM, Gong HY, Lu ZY, Chen J, Fang B, Chen C, Liu ZY. Remimazolam benzenesulfonate anesthesia effectiveness in cardiac surgery patients under general anesthesia. World J Clin Cases 2021; 9(34): 10595-10603
- URL: https://www.wjgnet.com/2307-8960/full/v9/i34/10595.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i34.10595